Hypercholesterolaemia and vascular dementia

JP Appleton, P Scutt, N Sprigg, PM Bath - Clinical Science, 2017 - portlandpress.com
Vascular dementia (VaD) is the second commonest cause of dementia. Stroke is the leading
cause of disability in adults in developed countries, the second major cause of dementia and …

Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke

PMW Bath, K Krishnan… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Nitric oxide (NO) has multiple effects that may be beneficial in acute stroke,
including lowering blood pressure, and promoting reperfusion and cytoprotection. Some …

Blood pressure management in acute stroke

JP Appleton, N Sprigg, PM Bath - Stroke and vascular neurology, 2016 - svn.bmj.com
Blood pressure (BP) is elevated in 75% or more of patients with acute stroke and is
associated with poor outcomes. Whether to modulate BP in acute stroke has long been …

[HTML][HTML] Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

N Sprigg, K Flaherty, JP Appleton, RAS Salman… - The Lancet, 2018 - thelancet.com
Background Tranexamic acid can prevent death due to bleeding after trauma and post-
partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma …

[HTML][HTML] Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia …

PM Bath, LJ Woodhouse, JP Appleton, M Beridze… - The Lancet, 2018 - thelancet.com
Background Intensive antiplatelet therapy with three agents might be more effective than
guideline treatment for preventing recurrent events in patients with acute cerebral …

[HTML][HTML] Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded …

PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge… - The Lancet, 2019 - thelancet.com
Background High blood pressure is common in acute stroke and is a predictor of poor
outcome; however, large trials of lowering blood pressure have given variable results, and …

Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke

JP Appleton, LJ Woodhouse, A Adami, JL Becker… - Neurology, 2020 - AAN Enterprises
Objective To assess the association of baseline imaging markers of cerebral small vessel
disease (SVD) and brain frailty with clinical outcome after acute stroke in the Efficacy of Nitric …

Clinical neurology: why this still matters in the 21st century

DJ Nicholl, JP Appleton - Journal of Neurology, Neurosurgery & …, 2015 - jnnp.bmj.com
This review argues that even with the tremendous advances in diagnostic neuroimaging that
the clinical skills involved in clinical neurology (ie, history, examination, localisation and …

Cilostazol for secondary prevention of stroke and cognitive decline: systematic review and meta-analysis

C McHutchison, GW Blair, JP Appleton, FM Chappell… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: Cilostazol, a phosphodiesterase 3'inhibitor, is used in Asia-
Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak …

Perfusion imaging for endovascular thrombectomy in acute ischemic stroke is associated with improved functional outcomes in the early and late time windows

PS Dhillon, W Butt, A Podlasek, N McConachie… - Stroke, 2022 - Am Heart Assoc
Background: The impact on clinical outcomes of patient selection using perfusion imaging
for endovascular thrombectomy (EVT) in patients with acute ischemic stroke presenting …